Novartis Vaccines and Diagnostics Inc vs Wyeth et al, No. 2:08-cv-00067 (E.D. Tex. Sept. 2, 2011)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Before the Court is Defendants Wyeth‟s and Wyeth Pharmaceuticals, Inc.‟s (collectively “Wyeth”) Motion for Reconsideration. (Dkt. No. 219.) For t he following reasons, Wyeth ‟s motion is DENIED. Plaintiff Novart is Vaccines and Diagnostics, Inc. (“Novartis” ) filed suit against Wyeth for patent infringement of U.S. Patent No. 6,228,620 ( “the „620 Patent”). The Court issued a Memorandum Opinion and Order on April 26, 2011 that outlined the Court‟s claim constructions for the various disputed claim terms.